FDA Inspection 1306616 - Novel Laboratories, Inc. d.b.a Lupin Somerset - April 17, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Novel Laboratories, Inc. d.b.a Lupin Somerset, with an inspection on April 17, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Novel Laboratories, Inc. d.b.a Lupin Somerset
Inspection Date: April 17, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 3929d635-0f63-4a0a-b47f-d35102bc3d33

Violation Codes3

21 CFR 211.19221 CFR 211.22(d)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.